Source: Reunion Neuroscience (formerly Field Trip Health)
  • Field Trip Health (FTRP) will release financial results for the fiscal second quarter after market close on Monday, November 15, 2021
  • The company will conduct a conference call and webcast to discuss its results on Tuesday, November 16 at 8:30 am ET
  • A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health Investor Relations website
  • Field Trip is a global leader in the development and delivery of psychedelic therapies
  • Field Trip Health Ltd. (FTRP) opened trading at C$6.60 per share

Field Trip Health (FTRP) will release financial results for the fiscal second quarter ended September 30, 2021, after market close on November 15.

The company will conduct a conference call and webcast to discuss its results on Tuesday, November 16 at 8:30 am ET. To access the call, please dial 1-877-407-9716 (within the U.S.) or 1-201-493-6779 (outside the U.S.) and provide conference ID 13724604.

A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health Investor Relations website here.

For those unable to attend the live call, a telephonic replay will be available until 11:59 pm ET on Tuesday, November 30, 2021. To access the replay of the call dial 1-844-512-2921 (within the U.S.) or 1-412-317-6671 (outside the U.S.) and provide conference ID 13724604.

An archived copy of the webcast will be available on the Events and Presentations section of the Field Trip Health Investor Relations website after the conclusion of the call.

Field Trip is a global leader in the development and delivery of psychedelic therapies.

Field Trip Health Ltd. (FTRP) opened trading at C$6.60 per share.

More From The Market Online

Canada’s federal budget: What investors need to know

Canada’s federal budget in has sent ripples through the investor community, revealing shifts in fiscal policies and spending priorities.

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.

CCrest Labs receives Red Light Holland’s largest psilocybin order

Red Light Holland's (CSE:TRIP) largest shipment to date of 5 kilograms of psilocybin truffles has been received by CCrest Labs in Montreal.